Objective Method for Pain Detection/Diagnosis

Award Information
Agency:
Department of Defense
Branch
Defense Health Program
Amount:
$149,988.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
W81XWH-13-C-0095
Agency Tracking Number:
H122-015-0012
Solicitation Year:
2012
Solicitation Topic Code:
DHP12-015
Solicitation Number:
2012.2
Small Business Information
BioSensics LLC
165 Pleasant St., Suit 302, Cambridge, MA, -
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
802270988
Principal Investigator:
Bor-rong Chen
Chief Technology Officer
(888) 589-6213
bor-rong.chen@biosensics.com
Business Contact:
Joseph Gwin
Vice President of Research and Dev
(888) 589-6213
joseph.gwin@biosensics.com
Research Institution:
Stub




Abstract
Pain is subjective and inherently difficult to quantify, yet appropriate pain management is predicated on adequate assessment. Whenever possible, pain is measured by the patient"s self-report. Patients who cannot reliably self-report are at significantly higher risk for inadequately managed pain. Therefore, there is a need for objective pain monitoring for noncommunicative patients. BioSensics LLC, in partnership with the University of Arizona, will develop a Multimodal Objective Pain Assessment Sensor System (MoPASS) consisting of two light, comfortable, wireless, wearable sensors (on the fingers and forehead) to monitor multiple indicators of pain and provide a single pain intensity score. This pain score will be based on proven pain correlates including behavioral parameters (restlessness and facial expression) and physiological parameters (electrocortical activity, heart-rate, skin conductance, and skin temperature). This system has broad applications ranging from rapid assessment in field-clinics to long-term monitoring of chronically noncommunicative patients. In Phase I we will develop the sensor system and perform a clinical feasibility study. In Phase II we will perform a comprehensive clinical study to examine the sensitivity and specificity of MoPASS. The results of this study will be used to pare down our system to the fewest possible sensing modalities for commercialization in Phase III.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government